GlobeNewswire
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
📈
AI Sentiment
Highly Positive
8/10
FibroGen Inc News
Latest updates and market news for FGEN
1 news
Dec 11 - Dec 17, 2025
Page 1
Share this news page